LC3 and P62 expression levels in peripheral blood lymphocytes of normal children (C), pre-treatment SEL (SLE), traditional treatment at the end of 6 months (A), sirolimus treatment at the end of 6 months (B) (x ̄ ± s). Here, MAP1LC3A is linked to systemic lupus erythematosus.